Legend Biotech Corp Stock Price Prediction
| LEGN Stock | USD 56.61 2.53 4.28% |
Oversold Vs Overbought
75
Oversold | Overbought |
EPS Estimate Next Quarter (0.44) | EPS Estimate Current Year (1.40) | EPS Estimate Next Year (0.68) | Wall Street Target Price 82.43 | EPS Estimate Current Quarter (0.34) |
Using Legend Biotech hype-based prediction, you can estimate the value of Legend Biotech Corp from the perspective of Legend Biotech response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Legend Biotech using Legend Biotech's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Legend using crowd psychology based on the activity and movement of Legend Biotech's stock price.
Legend Biotech Short Interest
An investor who is long Legend Biotech may also wish to track short interest. As short interest increases, investors should be becoming more worried about Legend Biotech and may potentially protect profits, hedge Legend Biotech with its derivative instruments, or be ready for some potential downside.
200 Day MA 55.9885 | Short Percent 0.1165 | Short Ratio 9.76 | Shares Short Prior Month 11.2 M | 50 Day MA 46.6416 |
Legend Biotech Corp Hype to Price Pattern
Investor biases related to Legend Biotech's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend Biotech Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Legend Biotech's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Legend Biotech.
Legend Biotech Implied Volatility | 104.37 |
Legend Biotech's implied volatility exposes the market's sentiment of Legend Biotech Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Legend Biotech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Legend Biotech stock will not fluctuate a lot when Legend Biotech's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Legend Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Legend because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Legend Biotech after-hype prediction price | USD 56.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Legend contract
Based on the Rule 16, the options market is currently suggesting that Legend Biotech Corp will have an average daily up or down price movement of about 6.52% per day over the life of the 2024-08-16 option contract. With Legend Biotech trading at USD 56.61, that is roughly USD 3.69 . If you think that the market is fully incorporating Legend Biotech's daily price movement you should consider acquiring Legend Biotech Corp options at the current volatility level of 104.37%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Legend |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Legend Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Legend Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Legend Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Legend Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Legend Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Legend Biotech Estimiated After-Hype Price Volatility
In the context of predicting Legend Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Legend Biotech's historical news coverage. Legend Biotech's after-hype downside and upside margins for the prediction period are 53.32 and 60.10, respectively. We have considered Legend Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Legend Biotech is very steady at this time. Analysis and calculation of next after-hype price of Legend Biotech Corp is based on 3 months time horizon.
Legend Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Legend Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Legend Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Legend Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.42 | 3.39 | 0.10 | 0.00 | 8 Events / Month | 2 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
56.61 | 56.71 | 0.18 |
|
Legend Biotech Hype Timeline
Legend Biotech Corp is now traded for 56.61. The entity has historical hype elasticity of 0.1, and average elasticity to hype of competition of 0.0. Legend is forecasted to increase in value after the next headline, with the price projected to jump to 56.71 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.18%, whereas the daily expected return is now at 0.42%. The volatility of related hype on Legend Biotech is about 61142.28%, with the expected price after the next announcement by competition of 56.61. The company reported the previous year's revenue of 285.14 M. Net Loss for the year was (518.25 M) with loss before overhead, payroll, taxes, and interest of (284.01 M). Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Legend Biotech Basic Forecasting Models to cross-verify your projections.Legend Biotech Related Hype Analysis
Having access to credible news sources related to Legend Biotech's direct competition is more important than ever and may enhance your ability to predict Legend Biotech's future price movements. Getting to know how Legend Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Legend Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DLTNF | Delta 9 Cannabis | 0.00 | 0 per month | 0.00 | (0.01) | 17.65 | (26.67) | 113.33 | |
| CVGRF | City View Green | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BHHKF | Benchmark Botanics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SPBBF | Speakeasy Cannabis Club | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PROCW | Procaps Group SA | 0.0001 | 1 per month | 14.24 | 0.01 | 27.81 | (25.45) | 114.93 | |
| SSIC | Silver Spike Investment | (0.18) | 7 per month | 1.22 | 0.04 | 3.13 | (2.09) | 9.98 | |
| EGRX | Eagle Pharmaceuticals | (0.52) | 8 per month | 4.45 | 0.06 | 9.27 | (6.81) | 19.81 | |
| PAHC | Phibro Animal Health | 0.47 | 12 per month | 1.88 | 0.11 | 6.15 | (3.60) | 36.18 | |
| COSM | Cosmos Health | 0.18 | 10 per month | 4.03 | 0.16 | 15.89 | (8.18) | 63.83 |
Legend Biotech Additional Predictive Modules
Most predictive techniques to examine Legend price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Legend using various technical indicators. When you analyze Legend charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Legend Biotech Predictive Indicators
The successful prediction of Legend Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Legend Biotech Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Legend Biotech based on analysis of Legend Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Legend Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Legend Biotech's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 44.49 | 1.99 | 8.17 | 7.76 | Days Of Inventory On Hand | 2.04 | 57.82 | 43.08 | 45.23 |
Story Coverage note for Legend Biotech
The number of cover stories for Legend Biotech depends on current market conditions and Legend Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Legend Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Legend Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Legend Biotech Short Properties
Legend Biotech's future price predictability will typically decrease when Legend Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Legend Biotech Corp often depends not only on the future outlook of the potential Legend Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Legend Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 176.1 M | |
| Cash And Short Term Investments | 1.3 B |
Additional Information and Resources on Investing in Legend Stock
When determining whether Legend Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotech Corp Stock:Check out Legend Biotech Basic Forecasting Models to cross-verify your projections. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.58) | Revenue Per Share 1.902 | Quarterly Revenue Growth 1.587 | Return On Assets (0.18) | Return On Equity (0.51) |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.